• English
  • العربية
  • 中文
  • Français
  • Русский
  • Español

You are here

Practical Guidance on Peptide Receptor Radionuclide Therapy (PRRNT) for Neuroendocrine Tumours

English STI/PUB/1560 978-92-0-129210-0
123 5 39.00 2013

Download PDF (1.24 MB)


This publication provides comprehensive multidisciplinary guidance to promote standardized, effective and safe implementation of best practices for treating neuroendocrine and gastroenteropancreatic tumours through applying peptide receptor radionuclide therapy (PRRNT). Taking into account the latest international classifications of neuroendocrine tumours, both PRRNT as a sole treatment and as a treatment in combination with other options are considered. Comprehensive protocols for employing either yttrium-90 or lutetium-177 tagged somatostatin receptor targeting peptides and clinically tested protocols for renal protection are presented. The publication comprises a comprehensive compilation of medical evidence and experience. Furthermore, it contains clinical presentations, eligibility criteria and means of assessing the effectiveness of therapy utilizing molecular and morphological medical imaging techniques. The publication is a practical reference for specialists in clinical oncology and in nuclear medicine deploying and executing a comprehensive programme for treating patients with neuroendocrine tumours.

More Information on reusing IAEA copyright material.

How to order

Ordering Locally

Please use the following links for an up-to-date list of IAEA distributors:

Distributors of IAEA Publications

Orders and requests for information may also be addressed to:

Marketing and Sales Unit
International Atomic Energy Agency
Vienna International Centre
PO Box 100, A-1400 Vienna,

Tel.: +43 1 2600 22529, +43 1 2600 22530
Fax: +43 1 2600 29302
Email: sales.publications@iaea.org

Download order form

How to Access IAEA e-books


  1. Employment
  2. Women
  3. Press

Stay in touch